A thorn in the side of the VACCINE STAKEHOLDERS and the VACCINE MACHINES, Professor Dolores Cahill addresses the Australian Health Alliance.
Her understanding of Immunology and Mapping of the Human Genome is super impressive.
When asked what we might expect as Negative Outcomes of the Clinical Trial Vaccines, the MAJOR CONCERNS include:
Sudden Adult Death ; brought about / precipitated by an infection of some sort and the vaccinated's immune response
Issues of Infertility (Perhaps by design)
Higher Incidences of Cancer where's the bodies Immune system has its cancer "checking" function compromised.
Professor Cahill shines a light on the Modus operandum of the Vaccine Stake Holders.
Professor Cahill also points out that Legal Precedent cases from Vaccine affected Persons against individuals is the spearhead into successful legal cases as opoosed to LEGAL cases which are institution versus institution.
Professor Cahill points out that there is more to come from "New World Order" proponet and the best we can do is prepare and be aware that other medical emergencies will be manifested by the Stakeholders
A window into the negative affects of the vaccinated in Covid19 can be ssen via the emerging UK data covered in other videos on this channel
See: https://www.bitchute.com/video/xBEFOt2YX1lS/
The Horrible Data Emerging for the Vaccinated in the UK
Recorded Live Wednesday 9th March 2022 and Hosted by Dan Hanson of Health Alliance Australia.
Drawing from more than 20 years expertise in high-throughput protein & antibody array, proteomics technology development, automation & biomedical applications in biomarker discovery, diagnostics & personalised medicine, Professor Cahill provides clear insight into why the science surrounding Covid-19 simply does not stack up.
Some Background on Professor Cahill;
Professor Dolores Cahill received her Honours degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology & Biotechnology from Dublin City University (1994). She was awarded an EU ‘Human Capital and Mobility’ Post-doctoral Fellow, Technical University, Munich, Germany (1994-1995).
Since 2005 – present, she is Professor of Translational Science at UCD School of Medicine. Prof. Cahill is internationally recognised for her biomedical research, publications and patent record is in life sciences, biotechnology and in personalised healthcare and biomarkers (PHB), proteomics, biotechnology, high content protein and antibody arrays, and their biomedical, diagnostic and clinical applications.
Prof. Cahill has been involved in Scientific and Research Strategy and Policy Development and Evaluation for over 10 years. She is a member of the EU Innovative Medicines Initiative (IMI) Science Committee (2017-2019). In 2018, she was elected by the IMI SC to be Vice Chair of the IMI Scientific Committee (2019-2020).
Thanks goes to :
https://www.healthallianceaustralia.org/
